Top compounds associated with response to LRRTM1


Feature Type Standardized
Nominal ANOVA
mRNA bendamustine CTRPv2 pan-cancer AAC 0.0061 0.9
mRNA IPA-3 GDSC1000 pan-cancer AAC -0.0054 0.9
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.0054 0.9
mRNA apicidin CTRPv2 pan-cancer AAC 0.005 0.9
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.0054 0.9
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0057 0.9
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.0051 0.9
mRNA CP466722 GDSC1000 pan-cancer AAC -0.0046 0.9
mRNA CIL55 CTRPv2 pan-cancer AAC -0.009 0.9
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.0056 0.9
Download CSV